Stay updated on PF-06480605 Efficacy in Ulcerative Colitis Clinical Trial
Sign up to get notified when there's something new on the PF-06480605 Efficacy in Ulcerative Colitis Clinical Trial page.

Latest updates to the PF-06480605 Efficacy in Ulcerative Colitis Clinical Trial page
- Check2 days agoChange DetectedThe web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference0.8%
- Check9 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference0.1%
- Check16 days agoNo Change Detected
- Check31 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.0%
- Check46 days agoChange DetectedThe webpage has been updated to include new dosing information for the drug PF-06480605 in the treatment of moderate to severe ulcerative colitis, along with a revision update to version 2.15.0. The previous detailed study description and inclusion/exclusion criteria have been removed.SummaryDifference10%
- Check53 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.0%
- Check60 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.0%
Stay in the know with updates to PF-06480605 Efficacy in Ulcerative Colitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PF-06480605 Efficacy in Ulcerative Colitis Clinical Trial page.